Chronic Kidney Disease
The Pharmacy Times® Chronic Kidney Disease resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Why is this man gaining weight, instead of losing it, while taking a natural supplement?
Of 400 dialysis patients with the Vall d’Hebron University Hospital as reference in Barcelona, Spain, 21 contracted the coronavirus disease 2019 (COVID-19) and the mortality rate in this center was 24%, according to the opening presentation at the ERA-EDTA Congress conference.
Previous clinical trials have shown that SGLT2 inhibitors protect kidney, or renal, function among patients with T2D, but their effect on serious renal events in patients in real-world clinical practice remains unclear.
Study shows sleep apnea is significantly associated with increased risk of death among patients with advanced chronic kidney disease (CKD) and end-stage renal disease.
The new guidelines recommend dosing vancomycin to achieve an area under the curve to minimum inhibitor concentration (AUC/MIC) ratio of ≥ 400.
Excessive alcohol consumption can damage the liver, thereby increasing the load on the kidneys to filter the blood stream.
Top news of the week across the healthcare landscape.
Top news from across the health care landscape.
Todd Brothers, PharmD, BCCCP, BCPS, clinical assistant professor, University of Rhode Island, discusses what patients should know about medications that cause hyperkalemia. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.
New Health Management Application Provides Daily Health Management to Patients with Chronic Kidney Failure
Through the Automatic LifeStyle Advice platform, health service providers can integrate personal health trackers, allowing data to configure the optimal recommendation for diet, exercise, and daily health management.
Study findings presented at the American Society of Nephrology’s Kidney Week 2019 suggest a link between chronic use of proton pump inhibitors and progression of kidney function decline in chronic kidney disease.
Baclofen use, particularly at higher doses, may result in an increased risk of encephalopathy among patients with chronic kidney disease.